Isochenodeoxycholic acid

• Description :

  Isochenodeoxycholic acid (isoCDCA) is a human fecal bile acid. Isochenodeoxycholic acid has cytoprotective against ethanol-induced cell injuries in HepG2 cells. Isochenodeoxycholic acid is a major metabolite of orally administered ursodeoxycholic acid (UDCA) [1].

• Product Name Alternative :

  IsoCDCA

• UNSPSC :

  12352211

• Hazard Statement :

  H301+H311+H331

• Target :

  Drug Metabolite

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Cancer; Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/isochenodeoxycholic-acid.html

• Purity :

  99.88

• Solubility :

  DMSO : 100 mg/mL (ultrasonic) |Ethanol : 8.33 mg/mL (ultrasonic)

• Smiles :

  C[C@@]12[C@](CC[C@]2([H])[C@H](C)CCC(O)=O)([H])[C@@]3([H])[C@@](CC1)([H])[C@@]4([C@](C[C@H](CC4)O)([H])C[C@H]3O)C

• Molecular Formula :

  C24H40O4

• Molecular Weight :

  392.57

• Precautions :

  H301+H311+H331

• References & Citations :

  [1]Marschall HU, et al. Isoursodeoxycholic acid: metabolism and therapeutic effects in primary biliary cirrhosis. J Lipid Res. 2001 May;42 (5) :735-42.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C (Powder, protect from light)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [566-24-5]